Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7586072rdf:typepubmed:Citationlld:pubmed
pubmed-article:7586072lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:7586072lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:7586072lifeskim:mentionsumls-concept:C1999177lld:lifeskim
pubmed-article:7586072lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7586072lifeskim:mentionsumls-concept:C0205549lld:lifeskim
pubmed-article:7586072lifeskim:mentionsumls-concept:C1516691lld:lifeskim
pubmed-article:7586072pubmed:issue9lld:pubmed
pubmed-article:7586072pubmed:dateCreated1995-12-19lld:pubmed
pubmed-article:7586072pubmed:abstractText2-(2-Aminoethoxy)-1-hydroxyethyl derivatives of bicyclic arenes (naphthalene, thianaphthene, benzofuran, and indole) were prepared and screened for antiamnestic (AA) and antihypoxic (AH) activities which were evaluated by measuring the reversing potency in electroconvulsion-induced amnesia and the protective effect against hypoxia, respectively, in mice. Compound 3o, 1-(benzo[b]thiophen-5-yl)-2- (2-diethylaminoethoxy)ethanol, showed the best AA and AH activity profile, being superior to our prototype compound, 2-(2-dimethylaminoethoxy)-1-phenylethanol (1). Elongation of the ethylene linkage in the side chain of 3o to 3- and 4-carbon moieties brought about a significant decrease in AH activity. Compound 3o was further investigated for its protective effect against CO2-induced memory impairment and for acute toxicity in mice. It is ten-fold more potent than tacrine in the amnesia-reversal assay and is considerably less toxic than tacrine.lld:pubmed
pubmed-article:7586072pubmed:languageenglld:pubmed
pubmed-article:7586072pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7586072pubmed:citationSubsetIMlld:pubmed
pubmed-article:7586072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7586072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7586072pubmed:statusMEDLINElld:pubmed
pubmed-article:7586072pubmed:monthSeplld:pubmed
pubmed-article:7586072pubmed:issn0009-2363lld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:TaiMMlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:OkadaNNlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:KitamuraKKlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:LIT JTJlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:NaritaHHlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:MaekawaMMlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:MoritaHHlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:TodoYYlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:YamafujiTTlld:pubmed
pubmed-article:7586072pubmed:authorpubmed-author:ChakiHHlld:pubmed
pubmed-article:7586072pubmed:issnTypePrintlld:pubmed
pubmed-article:7586072pubmed:volume43lld:pubmed
pubmed-article:7586072pubmed:ownerNLMlld:pubmed
pubmed-article:7586072pubmed:authorsCompleteYlld:pubmed
pubmed-article:7586072pubmed:pagination1492-6lld:pubmed
pubmed-article:7586072pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:meshHeadingpubmed-meshheading:7586072-...lld:pubmed
pubmed-article:7586072pubmed:year1995lld:pubmed
pubmed-article:7586072pubmed:articleTitleStudies on cognitive enhancing agents. III. Antiamnestic and antihypoxic activities of a series of 1-bicycloaryl-2-(omega-aminoalkoxy)ethanols.lld:pubmed
pubmed-article:7586072pubmed:affiliationResearch Laboratories, Toyama Chemical Co., Ltd., Japan.lld:pubmed
pubmed-article:7586072pubmed:publicationTypeJournal Articlelld:pubmed